Desoximetasone Patent Expiration

Desoximetasone is Used for treating plaque psoriasis in patients 18 years of age or older. It was first introduced by Taro Pharmaceutical Industries Ltd in its drug Topicort Lp on Approved Prior to Jan 1, 1982. Another drug containing Desoximetasone is Topicort. 16 different companies have introduced drugs containing Desoximetasone.


Desoximetasone Patents

Given below is the list of patents protecting Desoximetasone, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Topicort US8277780 Stable liquid desoximethasone compositions with reduced oxidized impurity Sep 01, 2028 Taro
Topicort US8715624 Stable liquid desoximethasone compositions with reduced oxidized impurity May 26, 2026 Taro
Topicort US5990100 Composition and method for treatment of psoriasis Mar 24, 2018

(Expired)

Taro



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Desoximetasone's patents.

Given below is the list recent legal activities going on the following patents of Desoximetasone.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 02 Apr, 2024 US8277780(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 08 Nov, 2021 US8715624(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 02 Apr, 2020 US8277780(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 27 Oct, 2017 US8715624(Litigated)
Change in Power of Attorney (May Include Associate POA) 09 Mar, 2017 US8715624(Litigated)
Email Notification 09 Mar, 2017 US8715624(Litigated)
Email Notification 07 Mar, 2017 US8277780(Litigated)
Change in Power of Attorney (May Include Associate POA) 07 Mar, 2017 US8277780(Litigated)
Correspondence Address Change 07 Mar, 2017 US8715624(Litigated)
Correspondence Address Change 06 Mar, 2017 US8277780(Litigated)


Desoximetasone's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Desoximetasone Generic API Manufacturers

Several generic applications have been filed for Desoximetasone. The first generic version for Desoximetasone was by Taro Pharmaceutical Industries Ltd and was approved on Nov 30, 1990. And the latest generic version is by Cosette Pharmaceuticals Inc and was approved on Mar 4, 2020.

Given below is the list of companies who have filed for Desoximetasone generic, along with the locations of their manufacturing plants worldwide.